EP0871489A1 - Arzneimittel zur verabreichung eines wirkstoffs an bzw. durch die oberfläche der haut bzw. schleimhaut - Google Patents

Arzneimittel zur verabreichung eines wirkstoffs an bzw. durch die oberfläche der haut bzw. schleimhaut

Info

Publication number
EP0871489A1
EP0871489A1 EP96934441A EP96934441A EP0871489A1 EP 0871489 A1 EP0871489 A1 EP 0871489A1 EP 96934441 A EP96934441 A EP 96934441A EP 96934441 A EP96934441 A EP 96934441A EP 0871489 A1 EP0871489 A1 EP 0871489A1
Authority
EP
European Patent Office
Prior art keywords
composition according
composition
phase
active substance
fatty acid
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP96934441A
Other languages
English (en)
French (fr)
Inventor
Lise Sylvest Nielsen
Jens Hansen
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sandberg Development AB
Original Assignee
GS Development AB
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by GS Development AB filed Critical GS Development AB
Publication of EP0871489A1 publication Critical patent/EP0871489A1/de
Withdrawn legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Liposomes
    • A61K9/1274—Non-vesicle bilayer structures, e.g. liquid crystals, tubules, cubic phases, cochleates; Sponge phases
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
EP96934441A 1995-10-12 1996-10-11 Arzneimittel zur verabreichung eines wirkstoffs an bzw. durch die oberfläche der haut bzw. schleimhaut Withdrawn EP0871489A1 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DK115095 1995-10-12
DK115095 1995-10-12
PCT/DK1996/000437 WO1997013528A1 (en) 1995-10-12 1996-10-11 A pharmaceutical composition for administration of an active substance to or through a skin or mucosal surface

Publications (1)

Publication Number Publication Date
EP0871489A1 true EP0871489A1 (de) 1998-10-21

Family

ID=8101575

Family Applications (1)

Application Number Title Priority Date Filing Date
EP96934441A Withdrawn EP0871489A1 (de) 1995-10-12 1996-10-11 Arzneimittel zur verabreichung eines wirkstoffs an bzw. durch die oberfläche der haut bzw. schleimhaut

Country Status (7)

Country Link
EP (1) EP0871489A1 (de)
JP (1) JPH11513393A (de)
AU (1) AU702030B2 (de)
CA (1) CA2231273A1 (de)
FI (1) FI980822A0 (de)
NO (1) NO981633L (de)
WO (1) WO1997013528A1 (de)

Families Citing this family (59)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6440980B1 (en) 1996-09-17 2002-08-27 Avanir Pharmaceuticals Synergistic inhibition of viral replication by long-chain hydrocarbons and nucleoside analogs
US6458373B1 (en) 1997-01-07 2002-10-01 Sonus Pharmaceuticals, Inc. Emulsion vehicle for poorly soluble drugs
AU6919598A (en) * 1997-04-17 1998-11-13 Dumex-Alpharma A/S A novel bioadhesive drug delivery system based on liquid crystals
US6887906B1 (en) 1997-07-01 2005-05-03 Isispharmaceuticals, Inc. Compositions and methods for the delivery of oligonucleotides via the alimentary canal
CA2299298A1 (en) * 1997-08-09 1999-02-18 Jane Elizabeth Hilton Compositions for nasal administration
AU747252B2 (en) * 1997-09-09 2002-05-09 Lyotropic Therapeutics, Inc. Coated particles, methods of making and using
SE9703458D0 (sv) * 1997-09-25 1997-09-25 Pharmacia & Upjohn Ab Nicotine compositions and methods of formulation thereof
EP1469009A2 (de) * 1998-05-21 2004-10-20 Isis Parmaceuticals, Inc. Zusammensetzungen und Verfahren für nicht-parenterale Verabreichung von Oligonukleotiden
US7030155B2 (en) 1998-06-05 2006-04-18 Sonus Pharmaceuticals, Inc. Emulsion vehicle for poorly soluble drugs
GB9827034D0 (en) * 1998-12-10 1999-02-03 Univ Manchester Delivery formulation
DE50008435D1 (de) * 1999-08-06 2004-12-02 Max Delbrueck Centrum Implantierbares wirkstoffdepot
AU2012101A (en) * 1999-12-20 2001-07-03 New Pharma Research Sweden Ab Veterinary compositions
DE10057769A1 (de) 2000-11-22 2002-05-23 Beiersdorf Ag Haarpflegeprodukte mit einem Gehalt an dispersen Flüssigkristallen, welche kubische Phasen darstellen
ES2327397T3 (es) * 2001-04-30 2009-10-29 TROMMSDORFF GMBH & CO. KG ARZNEIMITTEL Esteres de uridina farmaceuticamente activos.
US7439271B2 (en) * 2001-06-27 2008-10-21 The Gillette Company Reduction of hair growth
US20030124196A1 (en) 2001-08-22 2003-07-03 Susan Weinbach Pulsatile release compositions and methods for enhanced intestinal drug absorption
EP1667656A4 (de) * 2003-09-01 2011-12-28 Mayne Pharma Int Pty Ltd Zusammensetzungen und verfahren zur abgabe von biologisch wirksamen mitteln
EP1768650B1 (de) 2004-06-04 2008-07-16 Camurus Ab Flüssige depotformulierungen
US20060088596A1 (en) 2004-09-28 2006-04-27 Atrium Medical Corporation Solubilizing a drug for use in a coating
US9801982B2 (en) 2004-09-28 2017-10-31 Atrium Medical Corporation Implantable barrier device
EP1811935B1 (de) 2004-09-28 2016-03-30 Atrium Medical Corporation Wärmegehärtetes gel und herstellungsverfahren
US9012506B2 (en) 2004-09-28 2015-04-21 Atrium Medical Corporation Cross-linked fatty acid-based biomaterials
US9000040B2 (en) 2004-09-28 2015-04-07 Atrium Medical Corporation Cross-linked fatty acid-based biomaterials
DK1845942T3 (da) * 2005-01-14 2014-04-28 Camurus Ab GNRH-analogformuleringer
US8871712B2 (en) 2005-01-14 2014-10-28 Camurus Ab Somatostatin analogue formulations
US9649382B2 (en) 2005-01-14 2017-05-16 Camurus Ab Topical bioadhesive formulations
CA2594718C (en) * 2005-01-14 2012-01-24 Camurus Ab Gnrh analogue formulations
EP1843746B1 (de) * 2005-01-14 2011-03-16 Camurus Ab Somatostatin-analog-formulierungen
JP5127466B2 (ja) 2005-01-21 2013-01-23 カムルス エービー 医薬脂質組成物
MX2007014068A (es) * 2005-05-10 2008-02-07 Novartis Ag Composiciones farmaceuticas de liberacion modificada de famciclovir.
CN101217940B (zh) 2005-06-06 2013-03-27 卡穆鲁斯公司 Glp-1类似物制剂
US9427423B2 (en) 2009-03-10 2016-08-30 Atrium Medical Corporation Fatty-acid based particles
US9278161B2 (en) 2005-09-28 2016-03-08 Atrium Medical Corporation Tissue-separating fatty acid adhesion barrier
AU2006304590A1 (en) 2005-10-15 2007-04-26 Atrium Medical Corporation Hydrophobic cross-linked gels for bioabsorbable drug carrier coatings
BRPI0717769A2 (pt) 2006-10-17 2013-11-05 Nuvo Res Formulação de gel, método para o tratamento da osteoartrite em um indivíduo sofrendo de dor articular, e, uso de diclofenac de sódio
EP2626091B1 (de) 2006-11-06 2016-09-28 Atrium Medical Corporation Beschichtetes chirurgisches Netz
US9492596B2 (en) 2006-11-06 2016-11-15 Atrium Medical Corporation Barrier layer with underlying medical device and one or more reinforcing support structures
GB0711656D0 (en) 2007-06-15 2007-07-25 Camurus Ab Formulations
GB0716385D0 (en) 2007-08-22 2007-10-03 Camurus Ab Formulations
WO2009150134A1 (de) * 2008-06-09 2009-12-17 Boehringer Ingelheim International Gmbh Vorrichtung und verfahren zur ermittlung der eigenschaften von aerosolformulierungen
GB0815435D0 (en) 2008-08-22 2008-10-01 Camurus Ab Formulations
US8618164B2 (en) 2009-03-31 2013-12-31 Nuvo Research Inc. Treatment of pain with topical diclofenac compounds
US8546450B1 (en) 2009-03-31 2013-10-01 Nuvo Research Inc. Treatment of pain with topical diclofenac compounds
US10149824B2 (en) 2009-06-25 2018-12-11 Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd. Reverse hexagonal mesophases (HII) and uses thereof
US20110038910A1 (en) 2009-08-11 2011-02-17 Atrium Medical Corporation Anti-infective antimicrobial-containing biomaterials
EP2593141B1 (de) 2010-07-16 2018-07-04 Atrium Medical Corporation Zusammensetzung und verfahren zur veränderung der geschwindigkeit einer hydrolyse ausgehärteter materialien auf ölbasis
MX350964B (es) 2012-05-25 2017-09-27 Camurus Ab Formulaciones de agonistas del receptor de somatostatina.
US9867880B2 (en) 2012-06-13 2018-01-16 Atrium Medical Corporation Cured oil-hydrogel biomaterial compositions for controlled drug delivery
KR102098980B1 (ko) 2012-07-26 2020-04-08 카무러스 에이비 오피오이드 제형
WO2018191794A1 (en) 2017-04-20 2018-10-25 Zeenar Enterprises Pty Ltd Liquid crystalline dosage form for administering a statin
US20210330794A1 (en) * 2018-09-07 2021-10-28 Farnex Incorporated External preparation comprising non-lamellar liquid crystal-forming lipid
CA3117606A1 (en) * 2018-10-25 2020-04-30 Zeenar Enterprises Pty Ltd Composition that forms liquid crystalline particles
CN111821254B (zh) * 2019-04-18 2021-10-15 华东师范大学 一种抗病毒水凝胶及其制备方法和应用
CN111759858B (zh) * 2020-06-02 2022-09-20 杭州英健生物科技有限公司 pH敏感型消化道粘膜保护胶及其应用
CN112791047A (zh) * 2021-01-15 2021-05-14 中国人民解放军总医院第三医学中心 一种白藜芦醇层状液晶及其制备方法
CA3235606A1 (en) * 2021-10-19 2023-04-27 Sensach Ab Lipid patch
WO2023189270A1 (ja) * 2022-03-28 2023-10-05 富士フイルム株式会社 生体用組成物
WO2023189273A1 (ja) * 2022-03-28 2023-10-05 富士フイルム株式会社 生体用組成物
WO2024068672A1 (en) * 2022-09-26 2024-04-04 Universität Bern Structured lipid compositions

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2631282A1 (de) * 1976-07-12 1978-01-19 Kali Chemie Pharma Gmbh Verfahren zur erhoehung der loeslichkeit und des dispersitaetsgrades von schwerloeslichen arzneistoffen zum zwecke deren applikation in gelatinekapseln
SE457933B (sv) * 1987-07-06 1989-02-13 Larsson Kare Farmaceutisk komposition innefattande en vattendispergerad blandning av lipider, monoglycerider och fosfatidylkolin samt dess anvaendning foer framstaellning av en gastronintestinalt verksam kompostion
ES2119748T3 (es) * 1990-03-23 1998-10-16 Yoshitomi Pharmaceutical Composicion farmaceutica que contiene un farmaco ligeramente soluble en agua.
DK0752855T3 (da) * 1994-03-30 2000-01-03 Gs Dev Ab Anvendelse af fedtsyreestere som bioadhæsive substanser

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
See references of WO9713528A1 *

Also Published As

Publication number Publication date
FI980822A (fi) 1998-04-09
JPH11513393A (ja) 1999-11-16
AU7279296A (en) 1997-04-30
CA2231273A1 (en) 1997-04-17
NO981633D0 (no) 1998-04-08
FI980822A0 (fi) 1998-04-09
NO981633L (no) 1998-06-04
AU702030B2 (en) 1999-02-11
WO1997013528A1 (en) 1997-04-17

Similar Documents

Publication Publication Date Title
AU702030B2 (en) A pharmaceutical composition for administration of an active substance to or through a skin or mucosal surface
EP0975331A1 (de) Neues bioadhäsives arzneistoffabgabesystem auf basis von flüssigkristallen
AU685262B2 (en) Use of fatty acid esters as bioadhesive substances
US6228383B1 (en) Use of fatty acid esters as bioadhesive substances
AU2004291162B2 (en) Composition and dosage form comprising an amphiphilic molecule as a suspension vehicle
KR20000035801A (ko) 침투증강제로써라틱산지방산에스테르염
JPH08505850A (ja) 抗ウイルス局所用医薬組成物
WO2007070643A2 (en) Compositions and methods for treating dermatological conditions
WO2009029543A1 (en) Controlled release formulations
KR20000040846A (ko) 부프레놀핀을 함유하는 경피투여 조성물및 이를 포함하는 패취
ZA200604967B (en) Composition and dosage form comprising an amphiphilic molecule as a suspension vehicle
JPH08501089A (ja) ９−［（２−ヒドロキシエトキシ）メチルグアニン（アシクロヴィア）またはその塩もしくはエステルを含む抗ウイルス活性医薬水中油型エマルジョン
CZ2004778A3 (cs) Farmaceutická formule zahrnující cyklosporin a její použití
AU2021206858B2 (en) Isotretinoin formulations and uses and methods thereof
EP1517709A1 (de) Transdermales arzneimittelverabreichungssystem
JPH01165523A (ja) ネドクロミルナトリウム組成物およびその調製方法
JPH09169635A (ja) 経皮吸収製剤
GHANEM A REVIEW ON RECENT ADVANCES IN TRANSDERMAL DRUG DELIVERY SYSTEMS OF TAMSULOSIN
Anuroop et al. NEWER TRENDS IN FILM FORMING SYSTEMS FOR TOPICAL AND TRANSDERMAL DRUG DELIVERY
Waghmare et al. Vesicular Carrier for Transdermal Drug Delivery System–Ethosomes
CN115666537A (zh) 缓释医用硬膏剂
Siddanagowda Formulation, characterization and evaluation Of matrix type transdermal patches of a model Antihypertensive drug
Mandimika Evaluation of the Pharmaceutical Availability of Erythromycin from Topical Formulations
Junqueiraa et al. Transdermal Desmopressin as an Alternative Dosage Form for the Treatment of Nocturia

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 19980512

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AT BE CH DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE

17Q First examination report despatched

Effective date: 20001002

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN

18D Application deemed to be withdrawn

Effective date: 20010417